uncle, my position is that a full refinancing AT GOOD TERMS is less likely than a buyout for the simple reason that IMSC doesn't have a lot of control over $90m of debt. I understand your point, but IMO it is a certainty that big players out there want Implant's technology, and it is a certainty that they won't let $90m of debt hamper their attempts to get it. And it is a certainty that there is more than one that wants it -- therefore it is likely that we can get a pretty good buyout price given the basics: likely minimum $50m revs per year and positive or near positive EBITA going forward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.